{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:46:46Z","timestamp":1772027206655,"version":"3.50.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cancer cachexia is a complex inflammatory syndrome, which presents with a variety of discrete symptoms and signs. This creates a challenge for both clinicians and researchers in recognizing and assessing the syndrome. This review explores the evidence for various measures used in the assessment of cachexia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Objectively, cachexia may be assessed using CT-derived measures of skeletal muscle [skeletal muscle index (SMI) and skeletal muscle density (SMD)]. Evidence suggests that SMD may be of equal or greater value than SMI in assessing cachexia. Inflammatory markers are also used, and include interleukin(IL)-1\u03b1; IL-1\u03b2; IL-6 and Interferon Gamma (IFN\u03b3). Other robust measures include performance status and the modified Glasgow prognostic score (mGPS). These measures, however, are more commonly used in academia. By comparison, clinical assessment is limited to individual measures of patient function, such as hand grip strength (HGS), calf circumference, gait speed, and the \u2018timed up and go test\u2019 (TUG). These have each been linked with components of cachexia but are less well evidenced. Evidence also exists for patient-reported quality-of-life measures, based upon the EORTC- QLQ-C30 questionnaire, in assessing cachexia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Further assessment is required to compare clinical measures of cachexia and determine their utility.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000472","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T11:34:09Z","timestamp":1570707249000},"page":"323-327","source":"Crossref","is-referenced-by-count":14,"title":["Meaningful measures in cancer cachexia: implications for practice and research"],"prefix":"10.1097","volume":"13","author":[{"given":"James J.","family":"McDonald","sequence":"first","affiliation":[{"name":"Edinburgh Medical School, College of Medicine and Veterinary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie T.","family":"Fallon","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Molecular Medicine, University of Edinburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.A.","family":"Laird","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Molecular Medicine, University of Edinburgh"},{"name":"St Columba's Hospice, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230926","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R2-20230926","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","article-title":"An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status","volume":"67","author":"Sun","year":"2015","journal-title":"Nutr Cancer"},{"key":"R3-20230926","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20230926","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ctrv.2013.11.007","article-title":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score","volume":"40","author":"Douglas","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R5-20230926","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","article-title":"The central role of hypothalamic inflammation in the acute illness response and cachexia","volume":"54","author":"Burfeind","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R6-20230926","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12483","article-title":"Sarcopenia: a time for action. An SCWD Position Paper","author":"Bauer","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R7-20230926","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R8-20230926","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00520-014-2332-y","article-title":"Loss of muscle mass in the end of life in patients with advanced cancer","volume":"23","author":"Wallengren","year":"2015","journal-title":"Support Care Cancer"},{"key":"R9-20230926","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcsm.12357","article-title":"The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer","volume":"10","author":"Dolan","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R10-20230926","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/apha.12224","article-title":"Measurement of skeletal muscle radiation attenuation and basis of its biological variation","volume":"210","author":"Aubrey","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"key":"R11-20230926","doi-asserted-by":"crossref","first-page":"e0118022","DOI":"10.1371\/journal.pone.0118022","article-title":"Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series","volume":"10","author":"Gu","year":"2015","journal-title":"PLoS One"},{"key":"R12-20230926","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jcsm.12206","article-title":"Muscle mass and association to quality of life in nonsmall cell lung cancer patients","volume":"8","author":"Bye","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R13-20230926","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.clnu.2016.03.010","article-title":"Skeletal muscle radiodensity is prognostic for survival in patients with advanced nonsmall cell lung cancer","volume":"35","author":"Sjoblom","year":"2016","journal-title":"Clin Nutr"},{"key":"R14-20230926","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3892\/or.2015.4475","article-title":"Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer","volume":"35","author":"Hayashi","year":"2016","journal-title":"Oncol Rep"},{"key":"R15-20230926","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/1759-7714.12870","article-title":"Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in nonsmall cell lung cancer patients treated with first-line chemotherapy","volume":"9","author":"Cortellini","year":"2018","journal-title":"Thorac Cancer"},{"key":"R16-20230926","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R17-20230926","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13539-012-0075-5","article-title":"Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers","volume":"3","author":"Utech","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R18-20230926","doi-asserted-by":"crossref","first-page":"526.e9","DOI":"10.1016\/j.amjmed.2005.10.049","article-title":"Inflammatory markers and loss of muscle mass (sarcopenia) and strength","volume":"119","author":"Schaap","year":"2006","journal-title":"Am J Med"},{"key":"R19-20230926","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R20-20230926","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J Clin Oncol"},{"key":"R21-20230926","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2013-0120","article-title":"The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer","volume":"18","author":"Laird","year":"2013","journal-title":"Oncologist"},{"key":"R22-20230926","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/SPC.0000000000000398","article-title":"Targeting IL-1alpha in cancer cachexia: a narrative review","volume":"12","author":"McDonald","year":"2018","journal-title":"Curr Opin Support Palliat Care"},{"key":"R23-20230926","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance nonsmall cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"R24-20230926","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in nonsmall cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"R25-20230926","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eurger.2015.12.009","article-title":"Assessment of muscle mass, muscle strength and physical performance in clinical practice: an international survey","volume":"7","author":"Bruyere","year":"2016","journal-title":"Eur Geriatr Med"},{"key":"R26-20230926","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clnu.2010.02.007","article-title":"Determinants of hand grip strength, knee extension strength and functional status in cancer patients","volume":"29","author":"Norman","year":"2010","journal-title":"Clin Nutr"},{"key":"R27-20230926","first-page":"777","article-title":"Determinants and nutritional assessment value of hand grip strength in patients hospitalized with cancer","volume":"27","author":"Hu","year":"2018","journal-title":"Asia Pac J Clin Nutr"},{"key":"R28-20230926","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.archger.2019.04.012","article-title":"Maximal calf circumference reflects calf muscle mass measured using magnetic resonance imaging","volume":"83","author":"Asai","year":"2019","journal-title":"Arch Gerontol Geriatr"},{"key":"R29-20230926","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.rmu.2016.06.005","article-title":"Muscle mass measured using bioelectrical impedance analysis, calf circumference and grip strength in older adults","volume":"18","author":"Qui\u00f1onez-Olivas","year":"2016","journal-title":"Medicina Universitaria"},{"key":"R30-20230926","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/ggi.12377","article-title":"Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women","volume":"15","author":"Kawakami","year":"2014","journal-title":"Geriatr Gerontol Int"},{"key":"R31-20230926","first-page":"117","article-title":"Diagnostic performance of calf circumference, thigh circumference, and SARC-F Questionnaire to identify sarcopenia in elderly compared to Asian Working Group for Sarcopenia's Diagnostic Standard","volume":"51","author":"Mienche","year":"2019","journal-title":"Acta Med Indones"},{"key":"R32-20230926","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000052836","article-title":"Usefulness of calf circumference measurement in assessing the nutritional state of hospitalized elderly people","volume":"48","author":"Bonnefoy","year":"2002","journal-title":"Gerontology"},{"key":"R33-20230926","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.clnu.2013.07.013","article-title":"Calf circumference, frailty and physical performance among older adults living in the community","volume":"33","author":"Landi","year":"2014","journal-title":"Clin Nutr"},{"key":"R34-20230926","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12458","article-title":"Changes in knee extension peak torque and body composition and their relationship with change in gait speed","author":"Osawa","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R35-20230926","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12444","article-title":"Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living","author":"Perez-Sousa","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R36-20230926","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u2018Up & Go\u2019: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"R37-20230926","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10522-017-9717-5","article-title":"Aging effect on the instrumented Timed-Up-and-Go test variables in nursing home women aged 80-93 years","volume":"18","author":"Zarzeczny","year":"2017","journal-title":"Biogerontology"},{"key":"R38-20230926","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00520-018-4297-8","article-title":"A longitudinal study of muscle strength and function in patients with cancer cachexia","volume":"27","author":"Gale","year":"2019","journal-title":"Support Care Cancer"},{"key":"R39-20230926","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","article-title":"Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution","volume":"32A","author":"Buccheri","year":"1996","journal-title":"Eur J Cancer"},{"key":"R40-20230926","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.clon.2017.06.005","article-title":"Prediction of 90 day and overall survival after chemoradiotherapy for lung cancer: role of performance status and body composition","volume":"29","author":"Bowden","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R41-20230926","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00000421-198812000-00007","article-title":"A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study","volume":"11","author":"Finkelstein","year":"1988","journal-title":"Am J Clin Oncol"},{"key":"R42-20230926","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01635581.2018.1380206","article-title":"Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition","volume":"70","author":"Keane","year":"2018","journal-title":"Nutr Cancer"},{"key":"R43-20230926","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1200\/JOP.2014.000976","article-title":"Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic","volume":"11","author":"Moningi","year":"2015","journal-title":"J Oncol Pract"},{"key":"R44-20230926","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1200\/JCO.2008.20.2879","article-title":"Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer","volume":"27","author":"Sargent","year":"2009","journal-title":"J Clin Oncol"},{"key":"R45-20230926","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1007\/s00520-015-2923-2","article-title":"The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review","volume":"23","author":"Atkinson","year":"2015","journal-title":"Support Care Cancer"},{"key":"R46-20230926","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002800000176","article-title":"Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer","volume":"46","author":"Sengelov","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"R47-20230926","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0959-8049(97)00049-X","article-title":"Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy","volume":"33","author":"Coates","year":"1997","journal-title":"Eur J Cancer"},{"key":"R48-20230926","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S1478951509990216","article-title":"Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients","volume":"7","author":"Grande","year":"2009","journal-title":"Palliat Support Care"},{"key":"R49-20230926","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-8140(00)00158-4","article-title":"The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable nonsmall cell lung carcinoma treated with radiotherapy","volume":"55","author":"Langendijk","year":"2000","journal-title":"Radiother Oncol"},{"key":"R50-20230926","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.bjc.6604248","article-title":"The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer","volume":"98","author":"McKernan","year":"2008","journal-title":"Br J Cancer"},{"key":"R51-20230926","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","article-title":"Sarcopenia is associated with quality of life and depression in patients with advanced cancer","volume":"23","author":"Nipp","year":"2018","journal-title":"Oncologist"},{"key":"R52-20230926","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00277-008-0445-4","article-title":"EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression","volume":"87","author":"Pamuk","year":"2008","journal-title":"Ann Hematol"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:36:55Z","timestamp":1695713815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000472","relation":{},"ISSN":["1751-4258","1751-4266"],"issn-type":[{"value":"1751-4258","type":"print"},{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}